Jamie Dimon Says Private Credit Will Perform Far Worse Than Average
JPMorgan CEO Jamie Dimon cautioned that periods of calm in credit markets often mask the buildup of risk,…
Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic – Novo Nordisk (NYSE:NVO)
Novo Nordisk A/S (NYSE:NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a…
AI Bubble Fear? This Sector Is Quietly Surging While Tech Sinks – Amgen (NASDAQ:AMGN), Bristol-Myers Squibb (NYSE:BMY)
It hasn’t been an easy stretch for technology and AI stocks, with triple-digit year-to-date gainers like Palantir Technologies…
Trump-Pfizer Deal Pushes Health Care To Best Rally In 5 Years – Agilent Technologies (NYSE:A), Biogen (NASDAQ:BIIB)
Investors cheered a breakthrough drug pricing agreement between President Donald Trump and Pfizer Inc. (NYSE:PFE), sparking a sector-wide…
UnitedHealth Vs. Novo Nordisk: Which Healthcare Giant Fits Your Portfolio? – Novo Nordisk (NYSE:NVO), UnitedHealth Group (NYSE:UNH)
Two healthcare giants, UnitedHealth Group Inc UNH and Novo Nordisk A/S NVO, are duking it out in very…
Eli Lilly’s Orforglipron Data Is Not Disastrous: Analyst – Eli Lilly (NYSE:LLY)
Eli Lilly and Co LLY released underwhelming data from a Phase 3 ATTAIN-1 trial evaluating orforglipron, an investigational…
Is Trump Playing With Inflation Data?
Whispers of government manipulation are swirling after a quiet change in how inflation is measured. Since May, just…